相关实验视频

Updated: Sep 20, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

在SARS-CoV-2中抗病毒药物耐药性的演变

Roy Dinata¹, Piyush Baindara¹, Santi M Mandal²

¹Animal Science Research Center, Division of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.

|May 28, 2025

概括

SARS-CoV-2 变种和抗病毒药物耐药性的出现威胁着全球健康. 了解抵抗机制对于开发有效的COVID-19治疗方法至关重要.

科学领域:

病毒学病毒学
传染性疾病传染性疾病
药理学药理学是指药理学的学科.

背景情况:

尽管进行了大规模疫苗接种,但COVID-19流行病在全球范围内仍在持续,这是由SARS-CoV-2变种迅速出现所推动的.
现有的抗病毒药物如尼尔马特里尔维尔 (nirmatrelvir) 是有前途的,但药物重新定位和发现面临挑战,包括潜在的耐药性.
新出现的变种可以降低疫苗的疗效,增加抗病毒耐药性的可能性,加上污水处理等环境因素.

研究的目的:

审查SARS-CoV-2中药物耐药性的发展背后的战略和机制.
突出了解抗病毒耐药性的关键需求,以对抗COVID-19.
帮助开发有效的治疗方法来对抗新出现的耐药菌株.

主要方法:

关于SARS-CoV-2,病毒变体和抗病毒药物耐药性的科学出版物的文献综述.
分析导致药物耐药性的机制,包括病毒突变和环境因素.
综合有关治疗策略和对抗耐药菌株的挑战的信息.

主要成果:

SARS-CoV-2 变种可以逃避疫苗诱导的免疫力,并促进耐药性.
抗病毒药物的使用可以驱动突变导致耐药性.
废水处理抗病毒药物可能有助于耐药基因的环境传播.

结论:

了解SARS-CoV-2抗病毒耐药机制对于公共卫生至关重要.
开发新的抗病毒药物和克服耐药性的策略是优先考虑的.
减轻医疗保健威胁需要采取全面的方法来管理SARS-CoV-2的耐药性.

关键词:

在 COVID-19 疫情中,这就是SARS-CoV-2病毒.抗病毒药物抗病毒药物药物耐药性耐药性药物耐药性突变是发生在突变中的突变.

更多相关视频

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

相关概念视频

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

The Antiviral System of Bacteria and Archaea: CRISPR

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...